Fumiki Shimada
- Molecular Biology
- Cellular and Molecular Neuroscience
- Organic Chemistry
- Physiology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Kazuhiro SakuradaFiona McDonaldHiroshi KawazuraKatsuya KominamiHideyuki MigitaHitoshi KatoH. KatoYoshinobu Takata
- Topics
- Neuroscience and Neuropharmacology Research (5 papers)Glaucoma and retinal disorders (4 papers)Neurological Disorders and Treatments (4 papers)
- Journals
- Angewandte Chemie International EditionJournal of Pharmacology and Experimental TherapeuticsEuropean Journal of Pharmacology
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Fumiki Shimada
18 papers receiving 419 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 166
- Cellular and Molecular Neuroscience 115
- Organic Chemistry 47
- Physiology 46
- Radiology, Nuclear Medicine and Imaging 45
Countries citing papers authored by Fumiki Shimada
This map shows the geographic impact of Fumiki Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiki Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiki Shimada more than expected).
Fields of papers citing papers by Fumiki Shimada
This network shows the impact of papers produced by Fumiki Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiki Shimada. The network helps show where Fumiki Shimada may publish in the future.
Co-authorship network of co-authors of Fumiki Shimada
This figure shows the co-authorship network connecting the top 25 collaborators of Fumiki Shimada. A scholar is included among the top collaborators of Fumiki Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiki Shimada. Fumiki Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 25 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | 40 | |
| 6 | 63 | |
| 7 | 36 | |
| 8 | 8 | |
| 9 | 49 | |
| 10 | 4 | |
| 11 | 55 | |
| 12 | 38 | |
| 13 | 1 | |
| 14 | 10 | |
| 15 | 2 | |
| 16 | 23 | |
| 17 | 24 | |
| 18 | 32 |
About Fumiki Shimada
Fumiki Shimada is a scholar working on Neurology, Ophthalmology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 431 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Glaucoma and retinal disorders (4 papers) and Neurological Disorders and Treatments (4 papers). The work is most often cited by research in Physiology (31 citations), Cellular and Molecular Neuroscience (115 citations) and Developmental Neuroscience (22 citations). Fumiki Shimada has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Kazuhiro Sakurada, Fiona McDonald, Hiroshi Kawazura, Katsuya Kominami, Hideyuki Migita, Hitoshi Kato, H. Kato, Yoshinobu Takata, Akira Tamura and Yasushi Takata. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.